Studies in humans have found six de novo CDH2 missense mutations in EC5 associated with a variety of neurodevelopmental disorders, ranging from subtle disruptions of craniofacial morphogenesis and attention deficit to severe autistic disorders and intellectual disabilities [94]. This evidence concerns the gene CDH2 and autism.